Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trading involves risk
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
English (International)
Ashland Global Holdings Inc
Closed
SectorBasic materials
53.36 1.73
Overview
Share price change
24h
Min
51.8
Max
53.77
Income | 196M 31M |
|---|---|
Sales | 74M 479M |
Dividend yield | 3.27 |
Profit margin | 6.472 |
Employees | 3,200 |
EBITDA | 191M 51M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +32.38% upside |
Dividend yield Sector Avg | 3.27% 2.78% |
|---|---|
Next Earnings | 5 Aug 2025 |
Next Dividend date | 12 Sept 2025 |
Next Ex Dividend date | 29 Aug 2025 |
Market Cap | -203M 2.3B |
|---|---|
Previous open | 51.63 |
Previous close | 53.36 |
News Sentiment
By Acuity
50%
50%
75 / 168 Basic materials
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Ashland Global Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Ashland Global Holdings Inc Forecast
Price Target
By TipRanks
32.38% upside
12 Months Forecast
Average 69.5 USD 32.38%
High 85 USD
Low 60 USD
Based on 8 Wall Street analysts offering 12 month price targets forAshland Global Holdings Inc - Dist in the last 3 months.
Sentiment
By Acuity
75 / 168 Basic materials
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Ashland Global Holdings Inc
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
